Education
About Us
Working with TipRanks
Follow Us
Ronald Cecil Shnier Insider Profile
4 Followers
Ronald Cecil Shnier, Director at Vectus Biosystems Limited, holds 345.79K shares in Vectus Biosystems Limited (Ticker: AU:VBS). Most recently, Ronald Cecil Shnier Bought 37,500 shares of Vectus Biosystems Limited on Dec 29, 2022 for an estimated value of AU$30.00K.
Ronald Cecil Shnier has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ronald Cecil Shnier's holdings
Insider Roles
Director
Roles that Ronald Cecil Shnier holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ronald Cecil Shnier
Ronald Cecil Shnier's Trading History
List of latest transactions for each holding click on a transaction to see Ronald Cecil Shnier's performance on stock
You May Also Like
Ronald Cecil Shnier insider profile FAQ
What is the percentage of profitable transactions made by Ronald Cecil Shnier?
The percentage of profitable transactions made by Ronald Cecil Shnier is ―.
What is the average return per transaction made by Ronald Cecil Shnier?
The average return per transaction made by Ronald Cecil Shnier is ―.
What stocks does Ronald Cecil Shnier hold?
Ronald Cecil Shnier holds: AU:VBS stocks.
What was Ronald Cecil Shnier’s latest transaction?
Ronald Cecil Shnier latest transaction was an Informative Buy of AU$30.00K.
What was Ronald Cecil Shnier's most profitable transaction?
Ronald Cecil Shnier’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ronald Cecil Shnier's role in Vectus Biosystems Limited?
Ronald Cecil Shnier's role in Vectus Biosystems Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.